2021年11期
World Journal of Hepatology
REVIEW
- Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis:From clinical proteomics to microbiome
- Fatty acid metabolism and acyl-CoA synthetases in the liver-gut axis
- Liver involvement in inflammatory bowel disease:What should the clinician know?
- Chelation therapy in liver diseases of childhood:Current status and response
- Hepatocellular carcinoma:Understanding molecular mechanisms for defining potential clinical modalities
- Heterogeneity of non-alcoholic fatty liver disease:Implications for clinical practice and research activity
- Newly discovered endocrine functions of the liver
MINIREVIEWS
- Current strategies to induce liver remnant hypertrophy before major liver resection
- Health-related quality of life in autoimmune hepatitis
- Fungal infections following liver transplantation
- Elastography as a predictor of liver cirrhosis complications after hepatitis C virus eradication in the era of direct-acting antivirals
- Role of immune dysfunction in drug induced liver injury
- Hepatopulmonary syndrome:An update
- Mitochondrial hepatopathy:Respiratory chain disorders- ‘breathing in and out of the liver’
- Cystic fibrosis associated liver disease in children
- Abnormal liver enzymes:A review for clinicians
ORIGINAL ARTICLE
- Tumor characteristics of hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C:Comparative analysis with antiviral therapy-naive patients
- Circulating microRNA 9-3p and serum endocan as potential biomarkers for hepatitis C virus-related hepatocellular carcinoma
- Nonalcoholic fatty liver disease is associated with worse intestinal complications in patients hospitalized for Clostridioides difficile infection
- Six-minute walking test performance is associated with survival in cirrhotic patients